How Does eCAP™ Work?
eCAP™ is designed for applications where Med-ic® is not feasible. As it does not require blister package production it is flexible and can be organized by any local pharmacy without special training or tools. eCAP is ideal for pilot studies and extensive field projects. eCAP has its CPU embedded in a cap designed to fit a standard medication vial. The cap records each time the vial is opened to take a tablet or capsule. The cap is reusable at the time of refilling. eCAP can also incorporate optional auditory or visual reminders. The use of eCAP is analogous to that of Med-ic. At the time of refilling the prescription or during a clinical trial follow-up visit, the compliance data are downloaded via a CertiScan® RFID desktop Reader or NFC-enabled smart phone or tablet. The CertiScan Software can display the information immediately on a PC via an intuitive interface featuring point and click "drill down" capabilities ranging from daily to annual "at a glance" views. The interface can similarly be displayed on any NFC-enabled tablet or smart phone. Immediate display allows for on the spot targeted eduction to improve the patient's subsequent compliance. The data can also be exported to a variety of software solutions (eg: .pdf, .csv) for later use or analysis. CertiScan® Software uses a secure proprietary trial data file (.tdf) to record, store, display and retrieve electronic records of compliance data. The software extends electronic record compliance with 21 CFR Part 11 back directly to the patient source. No patient information is stored on eCAP, ensuring confidentiality. CPU-resident data comprise simply a sequence of numbers representing time-events that can only be related to a patient when the study code is broken by the sponsor. CertiScan can download data from both Med-ic and eCAP interchangeably. Inputting compliance data collected by the traditional methods of patient reports, medication diaries and pill counts is costly. eCAP obviates the need for the double entry data phase, virtually eliminating compliance data entry costs while offering researchers the most reliable and valid records of patient adherence to the study regimen.